SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: quidditch who wrote (50701)1/24/2019 11:28:30 AM
From: keokalani'nui  Read Replies (1) | Respond to of 52153
 
VKTX. A certain David Bautz, PhD, on behalf of zach's, gives his reasons for believing there in low cardio tox risk in 2809.

scr.zacks.com



To: quidditch who wrote (50701)1/24/2019 5:38:17 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
It's certainly an interesting study - I'll have to read more thoroughly.

One complication is that it is now thought that one early phenomenon in AD is partial loss of the blood brain barrier. That might allow infections to penetrate the brain earlier and might explain the correlation they are seeing.

There was a similar theory in heart disease (infection with the bacteria Chlamydophila pneumoniae) that did not pan out.

Peter



To: quidditch who wrote (50701)2/5/2019 12:27:37 PM
From: XenaLives  Respond to of 52153
 
Cortexyme is probably looking to IPO...



To: quidditch who wrote (50701)2/6/2019 10:05:42 AM
From: software salesperson3 Recommendations

Recommended By
Biotech Jim
George Statham
quidditch

  Respond to of 52153
 
alzforum.org

i suggest that you read the comments section, especially the one by Moir/Tanzi.